Prueksaritanond Nisa, Petchsila Kittisak, Insin Putsarat
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand.
College of Medicine, Rangsit University, Bangkok, Thailand.
World J Oncol. 2024 Dec;15(6):950-959. doi: 10.14740/wjon1963. Epub 2024 Oct 30.
The preoperative prognostic nutritional index (PPNI) has been investigated as a prognostic indicator in various cancers including epithelial ovarian cancer (EOC). However, its prognostic relevance in epithelial ovarian clear cell cancer (EOC-CC) remains uncertain. The objective of the study was to clarify the prognostic values of PPNI in EOC-CC patients.
We retrospectively reviewed 290 EOC-CC patients who underwent staging surgery at Rajavithi Hospital between January 2008 and December 2019. The PPNI was calculated using serum albumin × 10 (g/L) + 0.005 × peripheral blood lymphocyte count (per mm). The association between PPNI and survival outcome was analyzed using the Kaplan-Meier method and the Cox proportional hazard model.
The optimal cut-off value of PPNI, set at a mean of PPNI as 50, divided the EOC-CC patients into two groups: the low (n = 115) and the high (n = 175) PPNI group. With a median follow-up time of 63 months, patients with high PPNI exhibited significantly superior 5-year overall survival (OS) rates (76.4% vs. 56.8%, P = 0.004) and 5-year progression-free survival (PFS) rates (71.0% vs. 58.7%, P = 0.017) compared to patients with low PPNI. Univariate analysis revealed high PPNI correlated with increased OS (hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.35 - 0.75) and PFS (HR: 0.63; 95% CI: 0.43 - 0.92). Nevertheless, in a multivariate analysis, high PPNI did not retain its status as an independent prognostic factor for a favorable prognosis in EOC-CC patients.
The present study did not confirm the prognostic significance of PPNI on survival outcomes in EOC-CC patients. Therefore, conducting prospective clinical research with large samples is necessary to illustrate the predictive values of PPNI in this rare disease.
术前预后营养指数(PPNI)已被作为包括上皮性卵巢癌(EOC)在内的多种癌症的预后指标进行研究。然而,其在上皮性卵巢透明细胞癌(EOC-CC)中的预后相关性仍不确定。本研究的目的是阐明PPNI在上皮性卵巢透明细胞癌患者中的预后价值。
我们回顾性分析了2008年1月至2019年12月期间在拉贾维提医院接受分期手术的290例上皮性卵巢透明细胞癌患者。PPNI的计算方法为血清白蛋白×10(g/L)+0.005×外周血淋巴细胞计数(每立方毫米)。采用Kaplan-Meier法和Cox比例风险模型分析PPNI与生存结局之间的关联。
PPNI的最佳截断值设定为平均PPNI为50,据此将上皮性卵巢透明细胞癌患者分为两组:低PPNI组(n = 115)和高PPNI组(n = 175)。中位随访时间为63个月,高PPNI组患者的5年总生存率(OS)(76.4%对56.8%,P = 0.004)和5年无进展生存率(PFS)(71.0%对58.7%,P = 0.017)显著高于低PPNI组患者。单因素分析显示,高PPNI与OS增加(风险比(HR):0.51;95%置信区间(CI):0.35 - 0.75)和PFS增加(HR:0.63;95% CI:0.43 - 0.92)相关。然而,在多因素分析中,高PPNI并未保留其作为上皮性卵巢透明细胞癌患者良好预后独立预后因素的地位。
本研究未证实PPNI对上皮性卵巢透明细胞癌患者生存结局的预后意义。因此,有必要开展大样本的前瞻性临床研究,以阐明PPNI在这种罕见疾病中的预测价值。